CAS 615571-23-8

Fórmula: C20H20ClF3N2O

InChI: InChI=1S/C20H20ClF3N2O/c21-17-14(9-6-10-15(17)20(22,23)24)19(27)26-18(13-7-2-1-3-8-13)16-11-4-5-12-25-16/h1-3,6-10,16,18,25H,4-5,11-12H2,(H,26,27)/t16-,18-/m0/s1

Clave InChI: MEZRZVWPLXVLSO-WMZOPIPTSA-N

SMILES: C1CCN[C@@H](C1)[C@H](C2=CC=CC=C2)NC(=O)C3=C(C(=CC=C3)C(F)(F)F)Cl

SSR504734 HCl

CAS: 615571-23-8

SSR504734 HCl

Fórmula: C₂₀H₂₁Cl₂F₃N₂O

Pureza: 99.5%

Peso molecular: 433.3

Ref: 54-BUP11569

SSR504734 HCl

CAS: 615571-23-8

SSR504734 inhibits GlyT1 in humans, rats, mice (IC50=18, 15, 38 nM); treats schizophrenia, anxiety, depression orally.

Fórmula: C₂₀H₂₁Cl₂F₃N₂O

Pureza: 98.05% - 99.93%

Forma y color: Solid

Peso molecular: 433.295

Ref: TM-T90597

2-Chloro-N-((S)-phenyl((S)-piperidin-2-yl)methyl)-3-(trifluoromethyl)benzamide hydrochloride

CAS: 615571-23-8

Fórmula: C₂₀H₂₁Cl₂F₃N₂O

Forma y color: Solid

Peso molecular: 433.2947

Ref: IN-DA00EIW7

SSR 504734 hydrochloride

CAS: 615571-23-8

Inhibits GlyT1, a neurotransmitter transporter

Fórmula: C₂₀H₂₀ClF₃N₂O·HCl

Pureza: Min. 95%

Peso molecular: 433.29 g/mol

Ref: 3D-BS162755